10.3 Shock Syndromes: Hypovolemic, Cardiogenic, Septic & Anaphylactic

Shock Syndromes: Hypovolemic, Cardiogenic, Septic & Anaphylactic

Clinical Core: Circulatory shock is defined physiologically as widespread systemic hypoperfusion at the cellular and microvascular levels. When delivery of oxygenated blood fails to meet the metabolic requirements of peripheral tissues, cells transition from aerobic respiration to anaerobic glycolysis. This biochemical shift yields minuscule adenosine triphosphate (ATP), produces toxic lactic acid, disrupts membrane-bound sodium-potassium ATPase pumps, allows cellular swelling and lysis, and triggers inflammatory cascades that culminate in Multi-Organ Dysfunction Syndrome (MODS) and death if not aggressively reversed.

---

Pathophysiology & The Four Stages of Shock

Circulatory shock is not a static diagnosis; it represents a dynamic continuum progressing through four distinct pathophysiological stages.

1. Initial Stage

• Pathophysiology: Microvascular hypoperfusion begins without overt clinical manifestations. Cellular metabolism shifts to anaerobic pathways, producing excess lactate.
• Clinical Presentation: Often completely asymptomatic. Vital signs remain within normal parameters, though serum lactate may exhibit subtle elevation ($> 2.0\text{ mmol/L}$).

2. Compensatory (Non-Progressive) Stage

• Pathophysiology: Baroreceptors in the carotid sinus and aortic arch detect subtle decreases in stroke volume, triggering a massive release of catecholamines (epinephrine and norepinephrine) via the sympathetic nervous system. The renin-angiotensin-aldosterone system (RAAS) and antidiuretic hormone (ADH) are stimulated to retain sodium and water.
• Clinical Presentation:
  • Systolic blood pressure is maintained within normal limits!
  • Tachycardia ($HR > 100\text{ bpm}$) and Tachypnea ($RR > 20\text{ to }24\text{ breaths/min}$) to clear metabolic acids.
  • Narrowed Pulse Pressure (e.g., 105/85 mmHg; pulse pressure $\le 25\text{ mmHg}$) reflecting peripheral vasoconstriction.
  • Skin is cool, pale, and clammy with delayed capillary refill ($> 2\text{ seconds}$).
  • Mild anxiety, restlessness, and mild reduction in urine output.

3. Progressive (Decompensated) Stage

• Pathophysiology: Compensatory mechanisms are overwhelmed. Precapillary sphincters dilate in response to severe localized lactic acidosis and hypoxia, while postcapillary venules remain constricted. This massive increase in hydrostatic capillary pressure causes fluid extravasation into the interstitial space ("third-spacing"), causing profound intravascular hypovolemia, generalized tissue edema, and microthrombi formation.
• Clinical Presentation:
  • Frank Hypotension: Systolic blood pressure drops below 90 mmHg or drops $> 40\text{ mmHg}$ from baseline, and $\text{MAP} < 65\text{ mmHg}$.
  • Severe, weak, thready tachycardia ($HR > 120\text{ bpm}$).
  • Marked oliguria ($< 0.5\text{ mL/kg/hr}$) with rising blood urea nitrogen and serum creatinine.
  • Lethargy, confusion, somnolence, and obtundation due to cerebral hypoperfusion.
  • Peripheral cyanosis, cold mottled extremities, and marked metabolic acidosis on arterial blood gas.

4. Refractory (Irreversible) Stage

• Pathophysiology: Widespread cellular necrosis, microvascular collapse, and profound myocardial depression occur. The gut mucosal barrier fails, releasing endotoxins into the systemic circulation. Disseminated intravascular coagulation (DIC) consumes platelets and clotting factors, producing simultaneous multi-site thrombosis and profuse hemorrhage.
• Clinical Presentation: Multi-Organ Dysfunction Syndrome (MODS): anuria, hepatic necrosis, acute respiratory distress syndrome (ARDS), profound coma, intractable lactic acidosis, and bradyarrhythmias unresponsive to maximum inotropes and vasopressors. Death is clinically imminent.

---

Hemodynamic Profiles & Diagnostic Differentiation of Shock

Shock syndromes are categorized into four major classifications based on their underlying mechanical etiology: Hypovolemic, Cardiogenic, Distributive, and Obstructive.

---

Hypovolemic Shock: Volume Depletion & Hemorrhagic Resuscitation

Hypovolemic shock results from a critical loss of effective intravascular volume. It is classified into absolute hypovolemia (external fluid loss: massive hemorrhage, severe vomiting, persistent cholera-like diarrhea, large-surface burns) and relative hypovolemia (internal fluid redistribution: third-spacing in ascites, pancreatitis, or bowel obstruction).

Clinical Management Priorities

1. Stop Active Hemorrhage: External arterial or venous bleeding requires instant direct pressure, hemostatic gauze, or arterial tourniquets. Pelvic fractures require emergency sheet wrapping or commercial pelvic binders to reduce pelvic volume.
2. Large-Bore Vascular Access: Establish two 14-gauge or 16-gauge peripheral IV lines in the upper extremities. Central venous lines provide hemodynamic monitoring but have high internal resistance; short, wide peripheral lines deliver fluid boluses significantly faster.
3. Crystalloid Fluid Resuscitation: In non-hemorrhagic dehydration, infuse warmed isotonic balanced crystalloids (Ringer's Lactate is preferred over 0.9% Normal Saline to avoid hyperchloremic metabolic acidosis). Boluses of 20 to 30 mL/kg are titrated against hemodynamic markers.
4. Massive Transfusion Protocol (MTP): In severe hemorrhagic shock, crystalloids dilute clotting factors and worsen hypothermia. Activate MTP, infusing uncrossed O-negative packed red blood cells (O-positive for adult males), fresh frozen plasma, and platelets in a balanced 1:1:1 ratio. Administer intravenous calcium chloride or gluconate, as citrate preservatives in stored blood bind serum ionized calcium, impairing cardiac contractility and coagulation.

---

Cardiogenic Shock: Pump Failure & Myocardial Optimization

Cardiogenic shock occurs when primary myocardial failure results in an inability of the heart to pump sufficient blood to maintain systemic tissue perfusion, despite adequate or excessive intravascular volume. The most common cause is massive acute myocardial infarction (involving $>40\%$ of the left ventricle).

The Clinical Paradox & Distinguishing Features

Unlike hypovolemic shock, clients in cardiogenic shock present with fluid overload and pulmonary congestion:

• Auscultation reveals bilateral basilar lung crackles and a ventricular third heart sound ($S_3$ gallop).
• Physical exam demonstrates jugular venous distension (JVD), elevated central venous pressure ($CVP > 12\text{ to }15\text{ mmHg}$), peripheral edema, and acute pulmonary edema.

Clinical Management Priorities

• Fluid Restriction: Crystalloid fluid boluses are strictly contraindicated or limited to cautious small aliquots ($100\text{ to }250\text{ mL}$) only if right ventricular infarction is isolated. Aggressive fluids precipitate fatal pulmonary alveolar flooding.
• Inotropic Support: Administer Dobutamine (a beta-1 adrenergic agonist) to increase myocardial contractility and stroke volume without dramatically increasing heart rate or oxygen demand.
• Vasopressors: If profound hypotension threatens coronary perfusion ($\text{MAP} < 65\text{ mmHg}$), titrate Norepinephrine to maintain coronary perfusion pressure while minimizing excessive afterload.
• Afterload Reduction: Once systolic blood pressure is stabilized ($SBP > 90\text{ to }100\text{ mmHg}$), cautiously initiate intravenous Nitroglycerin or Sodium Nitroprusside to reduce left ventricular afterload and pulmonary capillary wedge pressure.
• Definitive Mechanical Interventions: Immediate transfer for primary percutaneous coronary intervention (PCI), coronary artery bypass grafting, or mechanical circulatory support (Intra-Aortic Balloon Pump [IABP] or Extracorporeal Membrane Oxygenation [ECMO]).

---

Distributive Shock: Septic, Anaphylactic & Neurogenic Syndromes

Distributive shock is characterized by profound, widespread pathological vasodilation and increased capillary permeability, resulting in a normal or increased blood volume that is improperly distributed within an abnormally expanded vascular capacity.

1. Septic Shock & The Surviving Sepsis Campaign Hour-1 Bundle

Septic shock represents a subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities are profound enough to substantially increase mortality. It is defined as sepsis with persistent hypotension requiring vasopressors to maintain $\text{MAP} \ge 65\text{ mmHg}$ and a serum lactate $> 2\text{ mmol/L}$ despite adequate volume resuscitation.

The Surviving Sepsis Campaign Hour-1 Bundle: All five bundle elements must be initiated immediately, ideally within 1 hour of recognition:

1. Measure blood lactate level. Remeasure within 2 to 4 hours if initial lactate is $> 2.0\text{ mmol/L}$.
2. Obtain blood cultures prior to starting antibiotics. Collect at least two sets of blood cultures (aerobic and anaerobic) from separate venipuncture sites without delaying antibiotic therapy beyond 1 hour.
3. Administer broad-spectrum intravenous antimicrobials. Empirical coverage targeting suspected pathogens must be initiated within 60 minutes.
4. Rapidly administer $30\text{ mL/kg}$ of intravenous crystalloid for hypotension ($\text{MAP} < 65\text{ mmHg}$) or serum lactate $\ge 4.0\text{ mmol/L}$. Balanced crystalloids (Ringer's Lactate) are infused rapidly.
5. Apply vasopressors if hypotensive during or after fluid resuscitation to achieve and maintain a target $\text{MAP} \ge 65\text{ mmHg}$. Norepinephrine is the first-line vasopressor of choice; add Vasopressin (0.03 units/min) if norepinephrine requirements escalate.

2. Anaphylactic Shock: Severe IgE-Mediated Collapse

Anaphylactic shock is an acute, life-threatening multi-system allergic reaction triggered by allergen exposure (medications like penicillin, insect stings, latex, foods). Massive degranulation of tissue mast cells and circulating basophils floods the circulation with histamine, leukotrienes, and prostaglandins.

• Clinical Manifestations: Sudden laryngeal edema, inspiratory stridor, severe bronchospasm with expiratory wheezing, diffuse pruritic urticaria, facial and periorbital angioedema, profound vasodilatory hypotension, and gastrointestinal cramping/diarrhea.
• Emergency Treatment Protocol:
  1. Discontinue the offending agent immediately (e.g., stop the antibiotic infusion; never flush the IV line containing the allergen!).
  2. Intramuscular Epinephrine (1:1,000 / $1\text{ mg/mL}$): The undisputed first-line life-saving medication. Administer $0.3\text{ to }0.5\text{ mg}$ IM into the anterolateral aspect of the middle third of the thigh (vastus lateralis). The vastus lateralis has extensive vascularity, achieving peak blood levels substantially faster than the deltoid or subcutaneous routes. Repeat every 5 to 15 minutes as needed for persistent symptoms.
  3. High-Flow Oxygen: Apply 100% oxygen via a non-rebreather mask (10-15 L/min). Prepare for emergent endotracheal intubation or cricothyroidotomy if laryngeal angioedema progresses.
  4. Aggressive IV Fluid Resuscitation: Infuse 1 to 2 liters of isotonic crystalloid rapidly to fill the massively dilated vascular bed.
  5. Secondary Pharmacological Adjuncts (Never delay epinephrine!):
     • Antihistamines: IV Diphenhydramine (H1 antagonist, 25 to 50 mg) plus IV Famotidine (H2 antagonist, 20 mg).
     • Corticosteroids: IV Methylprednisolone (125 mg) or IV Hydrocortisone (200 mg) to prevent biphasic late-phase reactions (which can recur 4 to 12 hours later).
     • Inhaled Bronchodilators: Nebulized Albuterol/Salbutamol for persistent bronchospasm.

3. Neurogenic Shock: Autonomic Vasomotor Collapse

Neurogenic shock results from acute traumatic injury to the spinal cord at or above the T6 level, causing disruption of descending sympathetic outflow from the brainstem while parasympathetic vagal innervation via the 10th cranial nerve remains intact.

• The Hallmark Triad:
  1. Profound Hypotension (loss of sympathetic vasomotor tone causes massive arterial and venous dilation).
  2. Paradoxical Bradycardia (loss of cardiac sympathetic accelerator fibers leaving unopposed vagal tone; pulse is $< 60\text{ bpm}$ despite hypotension).
  3. Warm, Dry, Flushed Skin (loss of sympathetic peripheral vasoconstriction and loss of sweating below the level of the spinal injury).
• Management: Judicious isotonic IV crystalloids, Vasopressors with alpha-1 and beta-1 activity (e.g., Norepinephrine, Phenylephrine) to restore vascular tone, and Atropine (0.5 to 1.0 mg IV) or transcutaneous pacing to treat symptomatic bradycardia.